tiprankstipranks
Trending News
More News >
TATA Health International Holdings Ltd. (HK:1255)
:1255
Hong Kong Market
Advertisement

TATA Health International Holdings Ltd. (1255) Ratios

Compare
8 Followers

TATA Health International Holdings Ltd. Ratios

HK:1255's free cash flow for Q2 2023 was HK$0.82. For the 2023 fiscal year, HK:1255's free cash flow was decreased by HK$ and operating cash flow was HK$-0.13. See a summary of the company’s cash flow.
Ratios
TTM
Dec 22Dec 21Dec 20Dec 19
Liquidity Ratios
Current Ratio
0.67 0.75 1.21 2.17-
Quick Ratio
0.53 0.61 0.75 0.87-
Cash Ratio
0.23 0.18 0.28 0.47-
Solvency Ratio
0.14 -0.35 -0.98 -0.24-
Operating Cash Flow Ratio
0.09 -0.03 <0.01 0.20-
Short-Term Operating Cash Flow Coverage
0.42 -0.16 <0.01 0.42-
Net Current Asset Value
HK$ -57.05MHK$ -51.70MHK$ -28.23MHK$ 71.58M-
Leverage Ratios
Debt-to-Assets Ratio
0.29 0.30 0.57 0.32-
Debt-to-Equity Ratio
1.52 2.29 9.20 0.64-
Debt-to-Capital Ratio
0.60 0.70 0.90 0.39-
Long-Term Debt-to-Capital Ratio
0.00 0.34 0.82 0.15-
Financial Leverage Ratio
5.23 7.69 16.01 1.99-
Debt Service Coverage Ratio
0.54 -1.59 -3.15 -0.64-
Interest Coverage Ratio
-12.05 -20.69 -38.38 -21.31-
Debt to Market Cap
0.14 0.11 0.15 0.10-
Interest Debt Per Share
0.22 0.24 0.45 0.49-
Net Debt to EBITDA
0.91 -0.50 -0.44 -1.74-
Profitability Margins
Gross Profit Margin
78.80%65.07%22.07%58.36%-
EBIT Margin
4.56%-41.25%-108.85%-18.90%-
EBITDA Margin
13.15%-32.34%-93.64%-9.44%-
Operating Profit Margin
-20.79%-35.44%-88.19%-17.86%-
Pretax Profit Margin
2.84%-42.97%-111.15%-19.73%-
Net Profit Margin
6.65%-43.78%-111.40%-19.57%-
Continuous Operations Profit Margin
2.22%-43.78%-111.40%-19.57%-
Net Income Per EBT
234.23%101.90%100.23%99.19%-
EBT Per EBIT
-13.65%121.24%126.04%110.49%-
Return on Assets (ROA)
5.46%-39.84%-107.22%-20.94%-
Return on Equity (ROE)
28.57%-306.19%-1717.05%-41.65%-
Return on Capital Employed (ROCE)
-109.02%-208.88%-228.49%-27.89%-
Return on Invested Capital (ROIC)
-33.56%-87.66%-118.06%-20.90%-
Return on Tangible Assets
4.35%-39.84%-107.22%-23.46%-
Earnings Yield
4.50%-19.10%-28.99%-8.64%-
Efficiency Ratios
Receivables Turnover
18.75 20.37 22.11 15.42-
Payables Turnover
3.23 17.61 64.82 23.61-
Inventory Turnover
1.45 2.87 2.59 1.08-
Fixed Asset Turnover
6.45 14.71 7.08 7.31-
Asset Turnover
0.82 0.91 0.96 1.07-
Working Capital Turnover Ratio
-3.35 -19.23 2.23 2.50-
Cash Conversion Cycle
158.44 124.33 151.80 344.86-
Days of Sales Outstanding
19.47 17.92 16.51 23.67-
Days of Inventory Outstanding
252.09 127.14 140.92 336.65-
Days of Payables Outstanding
113.11 20.73 5.63 15.46-
Operating Cycle
271.56 145.05 157.43 360.32-
Cash Flow Ratios
Operating Cash Flow Per Share
0.05 -0.02 <0.01 0.09-
Free Cash Flow Per Share
0.05 -0.03 -0.01 0.07-
CapEx Per Share
<0.01 <0.01 0.01 0.02-
Free Cash Flow to Operating Cash Flow
0.93 1.22 -11.10 0.75-
Dividend Paid and CapEx Coverage Ratio
14.68 -4.54 0.08 3.93-
Capital Expenditure Coverage Ratio
14.68 -4.54 0.08 3.93-
Operating Cash Flow Coverage Ratio
0.25 -0.09 <0.01 0.19-
Operating Cash Flow to Sales Ratio
0.09 -0.03 <0.01 0.06-
Free Cash Flow Yield
5.67%-1.62%-0.47%1.89%-
Valuation Ratios
Price-to-Earnings (P/E) Ratio
22.23 -5.24 -3.45 -11.58-
Price-to-Sales (P/S) Ratio
1.48 2.29 3.84 2.27-
Price-to-Book (P/B) Ratio
6.35 16.03 59.23 4.82-
Price-to-Free Cash Flow (P/FCF) Ratio
17.63 -61.74 -210.98 52.86-
Price-to-Operating Cash Flow Ratio
16.43 -75.35 2.34K 39.41-
Price-to-Earnings Growth (PEG) Ratio
-0.20 0.08 -0.02 <0.01-
Price-to-Fair Value
6.35 16.03 59.23 4.82-
Enterprise Value Multiple
12.15 -7.59 -4.55 -25.75-
Enterprise Value
231.09M 394.85M 661.62M 830.65M-
EV to EBITDA
12.15 -7.59 -4.55 -25.75-
EV to Sales
1.60 2.45 4.26 2.43-
EV to Free Cash Flow
19.07 -66.08 -233.79 56.68-
EV to Operating Cash Flow
17.77 -80.65 2.59K 42.26-
Tangible Book Value Per Share
0.08 0.06 0.05 0.65-
Shareholders’ Equity Per Share
0.14 0.10 0.05 0.75-
Tax and Other Ratios
Effective Tax Rate
0.22 -0.02 >-0.01 <0.01-
Revenue Per Share
0.60 0.69 0.73 1.60-
Net Income Per Share
0.04 -0.30 -0.81 -0.31-
Tax Burden
2.34 1.02 1.00 0.99-
Interest Burden
0.62 1.04 1.02 1.04-
Research & Development to Revenue
0.00 0.00 0.00 0.00-
SG&A to Revenue
0.57 0.60 0.65 0.29-
Stock-Based Compensation to Revenue
0.00 0.00 <0.01 <0.01-
Income Quality
3.17 0.07 >-0.01 -0.29-
Currency in HKD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis